MOG and myeloid sarcoma: Galazka and colleagues, analyzing the EV protein content in the serum and CSF of MS patients, discovered, for the first time, the myelin oligodendrocyte glycoprotein (MOG), the most immunogenic myelin protein, expressed only on the surface of myelin sheaths and the oligodendrocyte membrane, strongly related to disease activity [69].